SU1436882A3 - Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid - Google Patents
Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid Download PDFInfo
- Publication number
- SU1436882A3 SU1436882A3 SU864020682A SU4020682A SU1436882A3 SU 1436882 A3 SU1436882 A3 SU 1436882A3 SU 864020682 A SU864020682 A SU 864020682A SU 4020682 A SU4020682 A SU 4020682A SU 1436882 A3 SU1436882 A3 SU 1436882A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- cephem
- carboxylic acid
- formula
- amino
- propen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 5
- XQSQDNDZZYCEJU-BZSJEYESSA-N (6R)-4-amino-7-benzylidene-3-(3-chloroprop-1-enyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound C(C1=CC=CC=C1)=C1[C@@H]2N(C(=C(C(S2)N)C=CCCl)C(=O)O)C1=O XQSQDNDZZYCEJU-BZSJEYESSA-N 0.000 title 1
- PVQATPQSBYNMGE-UHFFFAOYSA-N [benzhydryloxy(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)OC(C=1C=CC=CC=1)C1=CC=CC=C1 PVQATPQSBYNMGE-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- -1 (3-chloro-1-propen-1-yl) -3-cephem 4-carboxylic acid diphenylmethyl ester Chemical compound 0.000 claims description 8
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 2
- FZDRVLJSDYQRPO-HWZXHQHMSA-N (6r)-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CC(C)S[C@@H]2CC(=O)N21 FZDRVLJSDYQRPO-HWZXHQHMSA-N 0.000 claims 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- LDECUSDQMXVUMP-UHFFFAOYSA-N benzyl 3-[6-[[2-(butylamino)-1-[3-methoxycarbonyl-4-(2-methoxy-2-oxoethoxy)phenyl]-2-oxoethyl]-hexylamino]-6-oxohexyl]-4-methyl-2-oxo-6-(4-phenylphenyl)-1,6-dihydropyrimidine-5-carboxylate Chemical compound O=C1NC(C=2C=CC(=CC=2)C=2C=CC=CC=2)C(C(=O)OCC=2C=CC=CC=2)=C(C)N1CCCCCC(=O)N(CCCCCC)C(C(=O)NCCCC)C1=CC=C(OCC(=O)OC)C(C(=O)OC)=C1 LDECUSDQMXVUMP-UHFFFAOYSA-N 0.000 claims 1
- 150000001782 cephems Chemical class 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 150000002148 esters Chemical class 0.000 abstract description 2
- 125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000002329 infrared spectrum Methods 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- QSKPIOLLBIHNAC-UHFFFAOYSA-N 2-chloro-acetaldehyde Chemical compound ClCC=O QSKPIOLLBIHNAC-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002211 ultraviolet spectrum Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- IKWLIQXIPRUIDU-ZCFIWIBFSA-N (6r)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2CC(=O)N12 IKWLIQXIPRUIDU-ZCFIWIBFSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 description 1
- DKWYZBFGYJOCJX-UHFFFAOYSA-N [iodo(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(I)C1=CC=CC=C1 DKWYZBFGYJOCJX-UHFFFAOYSA-N 0.000 description 1
- ZDJYLFBHGIPYHR-SNSSHHSLSA-N benzhydryl (6R)-7-(benzylideneamino)-3-(3-chloroprop-1-enyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C(C1=CC=CC=C1)=NC1[C@@H]2N(C(=C(CS2)C=CCCl)C(=O)OC(C2=CC=CC=C2)C2=CC=CC=C2)C1=O ZDJYLFBHGIPYHR-SNSSHHSLSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
0000
0000
ы s
Изобретение относитс к способу получени нового химического соединени , а именно дифекилметилового эфира 7-бензилиденамино-3-(3-Х1тор- -пропей- 1-ил)-З-цефем-4-карбоновой кисло ты, вл ющегос полупродуктом в синтезе новых антибиотиков цефалоспори- нового р да.This invention relates to a process for the preparation of a new chemical compound, namely, 7-benzylideneamino-3- (3-H1-3-propy-1-yl) 3-cephem-4-carboxylic acid diphekylmethyl ester, which is an intermediate in the synthesis of new cephalosporic antibiotics. - new p yes.
Целью изобретени вл етс получение нового полупродукта дл синте- за цефалоспориновых антибиотиков против ю-таммов микроорганизмов, устойчивых к известным антибиотикам пени- циллинового и цефалоспоринового р дов .The aim of the invention is to obtain a new intermediate for the synthesis of cephalosporin antibiotics against microorganisms resistant to the known antibiotics of the penicillin and cephalosporin series.
П р и м е р Ч. Получение дифенил- метил-7-бензилиденамино-З- f (трифе- ннлфосфоранилиден) метил 3-цефем- 4 карбоксилата.EXAMPLE CHP. Preparation of diphenylmethyl-7-benzylideneamino-3-f (triphenylphosphoranylidene) methyl 3-cephem-4 carboxylate.
А. хлорида дифенилме- тил 7-бенз1-тиденамино-3--трифенилфос- фониометил-3-цефем-А-карб.оксилата „A. Diphenylmethyl chloride 7-benz1-thienamino-3-triphenylphosphonomethyl-3-cephem-A-carboxyoxylate
К суспензии дифенилметил 7-ами-. но-З-хлорметил-З-цефем-4-карбоксила- та гидрохлорида (II гидрохлорид) (200 г, 0,44 моль) в метиленхлориде (940 мл)добавл ют 1н. гид;9Оокись натри (440 мл) при комнатной темпера- тзфе. Смесь- встр хивают в течение 10 мин и органический слой отдел ют . К органическому слою добавл ют сульфат магни (75 г) и бензальдегид (51 г, 0,48 моль) и смеси дают возмо ность сто ть в течение 3 ч, Реакцион HjTO смесь фильтруют и нерастворимые вещества промьшают метиленхлоридом (200 мл) . К объединенному фильтрату промьшным водам добавл ют трифенил- фосфин (126 г, 0,48 моль). Смесь кон центрируют до примерно 400 мл и оставл ют , сто ть в течение 4 дней. Получающеес в зкое масло разбавл ют этилацетатом (1 л) и растирают дл отделени целевого соединени в виде бледно-желтого кристаллического порошса, которьй собирают с помощью фильтровани и .сушат в вакууме. Выход 322 г (96%) . Температура плавлени 185-190 0 (разл.)To suspension diphenylmethyl 7-ami. but-3-chloromethyl-3-cephem-4-carboxylate hydrochloride (II hydrochloride) (200 g, 0.44 mol) in methylene chloride (940 ml) was added 1N. guide; sodium oxide (440 ml) at room temperature. The mixture is shaken for 10 minutes and the organic layer is separated. Magnesium sulfate (75 g) and benzaldehyde (51 g, 0.48 mol) are added to the organic layer and the mixture is allowed to stand for 3 hours. The reaction of the HjTO mixture is filtered and insoluble substances are washed with methylene chloride (200 ml). Triphenylphosphine (126 g, 0.48 mol) is added to the combined filtrate with industrial water. The mixture is concentrated to about 400 ml and left to stand for 4 days. The resulting viscous oil is diluted with ethyl acetate (1 L) and triturated to separate the desired compound as a pale yellow crystalline powder, which is collected by filtration and dried in vacuo. Yield 322 g (96%). Melting point 185-190 ° (decomp.)
ИК-спектр: (, (КВг), 1780; .1720; 1630.IR spectrum: (, (KBG), 1780; .1720; 1630.
УФ-спектр: д д (метиленхлорид), им (6): 260 (24100).UV spectrum: d d (methylene chloride), them (6): 260 (24100).
Б. Получение дифенилметил 7-бен- -зш1иденамино-3- Хтрифенилфосфорани- лиден) метил -З-цефем-4-карбоксйлата.B. Preparation of diphenylmethyl 7-benz-3a-1-amino-3-Htriphenylphosphoranilidene-methyl-3-cephem-4-carboxylate.
Смесь подукта со стадии А (322 г, 0,42 моль) и 5 и. карбоната натри A mixture of the product from stage A (322 g, 0.42 mol) and 5 and. sodium carbonate
00
5five
00
5 Q 5 Q
00
5five
5five
00
(252 мл) в етиленхлориде (1,6 л) перемешивают энергично в течение 15 мин при комнатной температуре. Органический слой отдел ют, сушат над сульфатом магни и концентрируют примерно до 500 мл объема. Концентрат добавл ют к ацетону (1 л) при перемешивании , получа светло-желтый кристаллический порошок, который собирают с помощью фильтровани с выходом 237 г (78%) целевого соединени , плав щегос при 195-198 С (разл.)(252 ml) in ethylene chloride (1.6 l) is stirred vigorously for 15 minutes at room temperature. The organic layer is separated, dried over magnesium sulfate, and concentrated to approximately 500 ml volume. The concentrate is added to acetone (1 L) with stirring to give a light yellow crystalline powder, which is collected by filtration to yield 237 g (78%) of the title compound, melting at 195-198 ° C (decomp.)
ИК-спектр: д с(КВг), :1770, 1620.IR spectrum: d s (KBG),: 1770, 1620.
УФ-спектр: А„акс (метиленхлорид), ;нм (П: 254 (23000); 389 (22000).UV spectrum: А „aks (methylene chloride),; nm (P: 254 (23000); 389 (22000).
ЯМР-спектр 5 (CDClj) млн.д:2,56 и 3,1б (2H,ABg), 5,00; (IH,дублет, J 4 Гц)5 5,23 (1Н, дублет, J 4 Гц); 5,47 (1Н,дублет I 22 Гц); 6,95 (1Ы, синглет); 7,2-7,8 (ЗОН, мультиплет), 8,55 (1Ы, синглет).NMR spectrum 5 (CDCl1) ppm: 2.56 and 3.1b (2H, ABg), 5.00; (IH, doublet, J 4 Hz) 5 5.23 (1H, doublet, J 4 Hz); 5.47 (1H, doublet, I 22 Hz); 6.95 (1Y, singlet); 7.2-7.8 (ZONE, multiplet), 8.55 (1Y, singlet).
В. Получение дифенилметил 7-бен- зилиденамино-3(трифенилфосфоранили- ден)метил3-3-цефем-4 карбоксилата.B. Preparation of diphenylmethyl 7-benzylideneamino-3 (triphenylphosphoranylidene) methyl 3-3 cephem-4 carboxylate.
К раствору йодистого дифенилметил 7-бенз1-шиданамин6-3-(три- фенилфосфонио)метш13-3-цефем-4-кар- , боксилата (60 г, 70 ммоль) в метиленхлориде (350 мл) добавл ют гидроокись натри (140 мл) и Амберлит lRA-410 (ОН форма, 35 г) при 5°С. Смесь перемешивают в течение 1 ч при и фильтруют. Органический слой от- отдел ют, сушат над сульфатом магни , концентрируют приблизительно до . 100 мл объема и осаждают этилацетатом (500 мл). Получающеес желтое твердое вещество собирают с помощью фильтровани и сушат в вакууме, получа 48 г (94%) целевого соединени , плав щегос при 195-8 С (разложение).To a solution of diphenylmethyl iodide 7-benz1-shidanamine6-3- (triphenylphosphonio) metsh13-3-cephem-4-car-, bauxilate (60 g, 70 mmol) in methylene chloride (350 ml) is added sodium hydroxide (140 ml) and Amberlite lRA-410 (OH form, 35 g) at 5 ° C. The mixture is stirred for 1 hour and filtered. The organic layer is separated, dried over magnesium sulfate, concentrated to approximately. 100 ml of volume and precipitated with ethyl acetate (500 ml). The resulting yellow solid was collected by filtration and dried in vacuo to give 48 g (94%) of the title compound, melting at 195-8 ° C (decomposition).
ИК-спектр (КБг), 1770, 1620.IR spectrum (KBg), 1770, 1620.
П р и м е р 2. Получение дифенилметил 7-бензилиденамино-3-(3-хлор-1- пропен-1-ил)-З-цефем-4-карбоксилата.PRI mme R 2. Preparation of diphenylmethyl 7-benzylidene-amino-3- (3-chloro-1-propen-1-yl) -3-cephem-4-carboxylate.
К перемешиваемому раствору целевого соединени примера 1Б или 1В (2,9 г, 4 ммоль) в смеси метиленхлори- да (40 мл) и ВОДЬ (10 мл) добавл ют безводный хлорацетальдегид (800 мг) при комнатной температуре. К смеси , добавл ют дополнительно 800 мг хлор- ацетальдегида трем порци ми на прот жении периода в 1 ч, при этом рН смеси поддерживают между 6 и 9 путем добавлени 1 н. гидроокиси натри .To a stirred solution of the title compound of Example 1B or 1B (2.9 g, 4 mmol) in a mixture of methylene chloride (40 ml) and WATER (10 ml) was added anhydrous chloroacetaldehyde (800 mg) at room temperature. To the mixture, an additional 800 mg of chloroacetaldehyde is added in three portions over a period of 1 hour, while the pH of the mixture is maintained between 6 and 9 by the addition of 1N. sodium hydroxide.
Спуст 15 мин водный слой удал ют, а органический слой сушат над сульфатом магни . Упаривание растворител дает красное масло, которое раствор - ют в смеси этилацетата и изопропило- вого эфира (1/2, 80 мл). Раствор про- мьшают последовательно насьщенным водным бикарбонатом натри (10 мл) и водой (10 мл). После сушки над сульфа- том магни удаление растворител дает 3,3 г желтого масла. Раствор масла в матиленхлориде (50 мл) фильтруют с помощью сидикагел (12 г, Ва- когель С-200),содержащего 1/1,5 М фосфатный буфер (1,2 мл, рН 6,4) и силикагель промывают метиленхлоридом (so мл) фильтрат и промывную воду объедин ют и упаривают досуха. Остаток растирают с к гексаном, получа 1,7 г (80%) целевого соединени в |Виде желтого порошка. Спектр-ЯМР показал , что хлорпропенильна часть молекулы имеет конфигурацию. Температура плавлени выше 50 С (разлож.) ИК-спектр,о,кс(КВг),см- : 3400} 1775; 1720; 1630.After 15 minutes, the aqueous layer was removed and the organic layer was dried over magnesium sulfate. Evaporation of the solvent gave a red oil, which was dissolved in a mixture of ethyl acetate and isopropyl ether (1/2, 80 ml). The solution is washed in succession with a saturated aqueous sodium bicarbonate (10 ml) and water (10 ml). After drying over magnesium sulphate, removal of the solvent gives 3.3 g of a yellow oil. The oil solution in matylene chloride (50 ml) is filtered using cedicagel (12 g, W-cogel C-200) containing 1 / 1.5 M phosphate buffer (1.2 ml, pH 6.4) and the silica gel is washed with methylene chloride (so ml) the filtrate and the wash water are combined and evaporated to dryness. The residue was triturated with hexane to give 1.7 g (80%) of the title compound in the form of a yellow powder. The NMR spectrum showed that the chloropropenyl part of the molecule has a configuration. Melting point above 50 ° C (decomposition). IR spectrum, o, kc (KBr), cm-: 3400} 1775; 1720; 1630.
УФ-спекгр /.(этагюп ) ,км (5): 253(11000); 258(11000); 265(10000); 273(8300); 281(7000),290(6300).UV spectrum /. (Etagüp), km (5): 253 (11000); 258 (11,000); 265 (10,000); 273 (8300); 281 (7000), 290 (6300).
ЯМР-спектр (DMCO-dfe), млн.д: 3,63 (2Г,шир.синглет.2-Н);4,0 (2Н, мультиплет, СН,г.-С1); 5,42 (2Н, мультиплет 6Н и ); 5,72 (1Н,дублет J 4,5, 7-Н); 6,27 (Ш, дублет, J 11,3-СН); 6,85 (Ш, синглет, CHPh)i 7,33 (ЮН, мультиплет , Ph2-H).NMR spectrum (DMSO-dfe), ppm: 3.63 (2G, s-sinlet.2-H); 4.0 (2H, multiplet, CH, g-C1); 5.42 (2H, multiplet 6H and); 5.72 (1H, doublet J 4.5, 7-H); 6.27 (W, doublet, J 11.3-CH); 6.85 (W, singlet, CHPh) i 7.33 (YUN, multiplet, Ph2-H).
Приготовление безводного хлор- ацетальдегида.Preparation of anhydrous chloroacetaldehyde.
Бозводный хлористый кальций добавл ют к охлажденному раствору 50%-ного водного хлорацетальдегида (50 мл) при перемешивании дл разделени его на два сло .Хлорацеталь- денид-гидратный слой (верхний слой) отдел ют и разбавл ют хлороформом (100 мл) смешивают с сульфатом магни (20 г), нагревают до кипени с обратным холодильником в течение 5 мин и фильтруют. Растворитель и воду удал ют азеотропно (температура кипени 56-64°С) и остаток перегон ют , получа безводный хлор- ацетальденид, температура кипени 70 82 с/760 мм рт.ст.Calcium chloride is added to a cooled solution of 50% aqueous chloroacetaldehyde (50 ml) with stirring to separate it into two layers. The chloroacetalide-hydride layer (upper layer) is separated and diluted with chloroform (100 ml) and mixed with sulfate magnesium (20 g), heated to reflux for 5 minutes and filtered. The solvent and water are removed azeotropically (boiling point 56-64 ° C) and the residue is distilled to give anhydrous chloroacetaldenide, boiling point 70 82 s / 760 mm Hg.
ИК-спектр : иакс (пленка) 1720смIR spectrum: iax (film) 1720cm
--
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59794184A | 1984-04-09 | 1984-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1436882A3 true SU1436882A3 (en) | 1988-11-07 |
Family
ID=24393575
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU864023036A SU1367858A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing cephalosporin derivatives |
| SU864018257A SU1375140A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing derivatives of cephalosporin or additive salts thereof with hydrogen halide acids |
| SU864020682A SU1436882A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid |
| SU864019975A SU1487814A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing 7-amino-3-/3-(4-carbamoyl-1-pyridino)-1-propene-1-yl/-3-cephem-4-carboxylate |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU864023036A SU1367858A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing cephalosporin derivatives |
| SU864018257A SU1375140A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing derivatives of cephalosporin or additive salts thereof with hydrogen halide acids |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU864019975A SU1487814A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing 7-amino-3-/3-(4-carbamoyl-1-pyridino)-1-propene-1-yl/-3-cephem-4-carboxylate |
Country Status (31)
| Country | Link |
|---|---|
| JP (4) | JPS615084A (en) |
| KR (1) | KR870002166B1 (en) |
| AR (1) | AR244694A1 (en) |
| AT (1) | AT388735B (en) |
| AU (2) | AU580990B2 (en) |
| BE (1) | BE902148A (en) |
| CA (3) | CA1276929C (en) |
| CH (1) | CH669197A5 (en) |
| DD (3) | DD249024A5 (en) |
| DE (1) | DE3512225A1 (en) |
| DK (1) | DK155985A (en) |
| ES (4) | ES8607318A1 (en) |
| FI (1) | FI84830C (en) |
| FR (1) | FR2563832B1 (en) |
| GB (3) | GB2157293B (en) |
| GR (1) | GR850883B (en) |
| HU (2) | HU193750B (en) |
| IE (2) | IE58408B1 (en) |
| IL (1) | IL74826A (en) |
| IT (1) | IT1190353B (en) |
| LU (1) | LU85840A1 (en) |
| MY (1) | MY101940A (en) |
| NL (1) | NL192925C (en) |
| NZ (1) | NZ211659A (en) |
| OA (1) | OA07985A (en) |
| PT (1) | PT80246B (en) |
| RU (1) | RU2056425C1 (en) |
| SE (4) | SE466205B (en) |
| SU (4) | SU1367858A3 (en) |
| YU (2) | YU46151B (en) |
| ZA (1) | ZA852236B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61145186A (en) * | 1984-12-20 | 1986-07-02 | Meiji Seika Kaisha Ltd | Novel cephem compound and preparation thereof |
| US4708955A (en) * | 1985-06-24 | 1987-11-24 | Bristol-Myers Company | 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof |
| ATE114657T1 (en) * | 1985-12-26 | 1994-12-15 | Eisai Co Ltd | CEPHALOSPORIN COMPOUNDS. |
| AU614723B2 (en) * | 1986-10-13 | 1991-09-12 | Eisai Co. Ltd. | 3-propenylcephem derivative |
| IL84128A (en) * | 1986-10-13 | 1992-12-01 | Eisai Co Ltd | 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them |
| JPH085897B2 (en) * | 1986-11-06 | 1996-01-24 | エーザイ株式会社 | 3-propenyl cephem derivative |
| FR2622585B1 (en) * | 1987-11-03 | 1991-04-19 | Roussel Uclaf | NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A SUBSTITUTED VINYL RADICAL, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED |
| JPH0699449B2 (en) * | 1988-03-16 | 1994-12-07 | エーザイ株式会社 | Synthetic intermediate of cephem derivative |
| DE68928174T2 (en) * | 1988-03-16 | 1997-12-18 | Eisai Co., Ltd., Tokio/Tokyo | Process for the preparation of cephem derivatives |
| FR2655042B1 (en) * | 1989-11-29 | 1994-01-21 | Adir Cie | NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| FR2663332B1 (en) * | 1990-06-15 | 1997-11-07 | Roussel Uclaf | NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A RADICAL PROPENYL SUBSTITUTED BY A QUATERNARY AMMONIUM, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED. |
| US5126336A (en) * | 1990-08-23 | 1992-06-30 | Bristol-Myers Squibb Company | Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| AT396108B (en) * | 1991-08-21 | 1993-06-25 | Biochemie Gmbh | NEW PROCESS AND NEW INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES |
| JPH0741484A (en) * | 1993-07-29 | 1995-02-10 | Katayama Seiyakushiyo:Kk | Cephem compound and antimicrobial agent |
| WO1996005205A1 (en) * | 1994-08-16 | 1996-02-22 | Meiji Seika Kabushiki Kaisha | Novel cephem derivative |
| ID28433A (en) | 1998-06-22 | 2001-05-24 | Hoffmann La Roche | PROPENIL SEFALOSPORIN DEPOSITS |
| CN100398547C (en) | 2003-09-09 | 2008-07-02 | 日本化学工业株式会社 | Process for producing 3-chloromethyl-3-cephem derivatives |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1342241A (en) * | 1970-01-23 | 1974-01-03 | Glaxo Lab Ltd | Cephalosporin compounds |
| US4390534A (en) * | 1978-12-29 | 1983-06-28 | Fujisawa Pharmaceutical Co., Ltd. | Cephem and cepham compounds |
| EP0025017A1 (en) * | 1979-08-28 | 1981-03-11 | Ciba-Geigy Ag | Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter |
| US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
| GR75644B (en) * | 1980-06-18 | 1984-08-02 | Fujisawa Pharmaceutical Co | |
| GR78245B (en) * | 1980-09-12 | 1984-09-26 | Ciba Geigy Ag | |
| US4521413A (en) * | 1981-09-14 | 1985-06-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4486586A (en) * | 1983-02-10 | 1984-12-04 | Bristol-Myers Company | Cephalosporin derivatives |
-
1985
- 1985-02-14 CA CA000474260A patent/CA1276929C/en not_active Expired - Lifetime
- 1985-03-25 ZA ZA852236A patent/ZA852236B/en unknown
- 1985-04-02 NZ NZ211659A patent/NZ211659A/en unknown
- 1985-04-02 AR AR85299945A patent/AR244694A1/en active
- 1985-04-03 SE SE8501680A patent/SE466205B/en not_active IP Right Cessation
- 1985-04-03 DE DE19853512225 patent/DE3512225A1/en active Granted
- 1985-04-03 DD DD85287524A patent/DD249024A5/en unknown
- 1985-04-03 DD DD85274832A patent/DD236735A5/en unknown
- 1985-04-03 DK DK155985A patent/DK155985A/en not_active Application Discontinuation
- 1985-04-04 CH CH1498/85A patent/CH669197A5/en not_active IP Right Cessation
- 1985-04-04 OA OA58561A patent/OA07985A/en unknown
- 1985-04-04 FI FI851379A patent/FI84830C/en not_active IP Right Cessation
- 1985-04-04 NL NL8501002A patent/NL192925C/en not_active IP Right Cessation
- 1985-04-04 AU AU40862/85A patent/AU580990B2/en not_active Expired
- 1985-04-04 GB GB08508846A patent/GB2157293B/en not_active Expired
- 1985-04-04 PT PT80246A patent/PT80246B/en unknown
- 1985-04-04 IE IE86685A patent/IE58408B1/en not_active IP Right Cessation
- 1985-04-05 IT IT20267/85A patent/IT1190353B/en active
- 1985-04-05 AT AT0103985A patent/AT388735B/en not_active IP Right Cessation
- 1985-04-05 FR FR8505281A patent/FR2563832B1/en not_active Expired
- 1985-04-05 LU LU85840A patent/LU85840A1/en unknown
- 1985-04-05 IL IL74826A patent/IL74826A/en not_active IP Right Cessation
- 1985-04-08 ES ES542013A patent/ES8607318A1/en not_active Expired
- 1985-04-08 RU SU853878102A patent/RU2056425C1/en active
- 1985-04-08 GR GR850883A patent/GR850883B/el not_active IP Right Cessation
- 1985-04-09 YU YU60085A patent/YU46151B/en unknown
- 1985-04-09 KR KR1019850002383A patent/KR870002166B1/en not_active Expired
- 1985-04-09 JP JP60075233A patent/JPS615084A/en active Granted
- 1985-04-09 BE BE0/214810A patent/BE902148A/en not_active IP Right Cessation
- 1985-04-09 HU HU851299A patent/HU193750B/en unknown
- 1985-04-09 HU HU87151A patent/HU204277B/en unknown
- 1985-11-12 JP JP60252140A patent/JPS61143387A/en active Granted
- 1985-11-12 JP JP60252138A patent/JPS61143390A/en active Granted
- 1985-11-12 JP JP60252139A patent/JPS61143391A/en active Granted
-
1986
- 1986-01-31 ES ES551550A patent/ES8706155A1/en not_active Expired
- 1986-01-31 ES ES551551A patent/ES8706694A1/en not_active Expired
- 1986-02-06 SU SU864023036A patent/SU1367858A3/en active
- 1986-02-06 SU SU864018257A patent/SU1375140A3/en active
- 1986-02-06 SU SU864020682A patent/SU1436882A3/en active
- 1986-02-06 SU SU864019975A patent/SU1487814A3/en active
- 1986-03-03 DD DD86287525A patent/DD251752A5/en unknown
- 1986-09-10 ES ES557060A patent/ES8800949A1/en not_active Expired
-
1987
- 1987-06-25 YU YU118987A patent/YU46213B/en unknown
- 1987-09-10 GB GB08721346A patent/GB2194789B/en not_active Expired
- 1987-09-10 GB GB08721347A patent/GB2194790B/en not_active Expired
- 1987-10-01 MY MYPI87002761A patent/MY101940A/en unknown
-
1988
- 1988-11-11 AU AU25041/88A patent/AU610278B2/en not_active Expired
-
1989
- 1989-04-04 IE IE121089A patent/IE58403B1/en not_active IP Right Cessation
- 1989-04-06 SE SE8901224A patent/SE470259B/en not_active IP Right Cessation
- 1989-04-06 SE SE8901225A patent/SE505256C2/en not_active IP Right Cessation
- 1989-04-06 SE SE8901226A patent/SE470260B/en not_active IP Right Cessation
-
1991
- 1991-08-12 CA CA000616143A patent/CA1340638C/en not_active Expired - Fee Related
- 1991-08-21 CA CA000616144A patent/CA1340672C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| Патент СССР № 1181548А, кл. С 07 D 501/18, 1979. Патент US № 4065620, кл. 544-16, опублик.1977. Патент US № 4110534, кл. 544-16, опублик, 1978. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1436882A3 (en) | Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid | |
| SE434949B (en) | PROCEDURE FOR PREPARING 7BETA-ACYLAMINO-7ALFA-ALCOXICEPHALOSPORINES OR 6BETA-ACYLAMINO-6ALFA-ALCOXIPENICILLINES | |
| DK163584B (en) | 7-AMINO-3-PROPENYLECEPHALOSPORIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
| US4699979A (en) | 7-amino-3-propenylcephalosporanic acid and esters thereof | |
| US4139618A (en) | Cephalosporin type antibacterials | |
| US4094978A (en) | 3-propenyl derivatives of cephalosporin, compositions and their use | |
| FI75165B (en) | FOERBAETTRAT FOERFARANDE FOER FRAMSTAELLNING AV PENICILLANSYRAKLORMETYLESTRAR. | |
| GB2101986A (en) | Thiazolinoazetidinone derivatives | |
| US5919939A (en) | Preparation of cephem and isooxacephem derivatives | |
| US3998817A (en) | Process for producing cephalosporanic acid derivatives | |
| EP0055933B1 (en) | 6-(2-aryl-2-(1,1-dioxopenicillanoyloxy-methoxycarbonyl)acetamido) penicillanic acids | |
| US4051131A (en) | Intermediates for preparing cephalosporins | |
| US3965098A (en) | Intermediates for preparing cephalosporins and methods of production | |
| EP0117872B1 (en) | Process for preparing cephalosporin compounds | |
| SU797579A3 (en) | Method of preparing acid amides or their salts with alkaline metals or trialkylamines | |
| SU685157A3 (en) | Method of obtaining 7-amino-3-/(1-carboxymethylterazol-5-yl)/-3-cephem-4-carboxylic acid | |
| US4171303A (en) | Process for the preparation of reactive penicillanic acid and cephalosporanic acid derivatives | |
| US4210750A (en) | Process for the preparation of 3-carbamoyl cephalosporins using isocyanates | |
| US4959495A (en) | Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins | |
| US3799922A (en) | 4-substituted 3-cephem compounds | |
| US3971780A (en) | Thio-β-lactam cephalosporins | |
| EP0049309B1 (en) | Cephem derivatives, process for producing thereof, and antibacterial agents comprising said compounds | |
| US4659812A (en) | Cephalosporin intermediates | |
| EP0096496B1 (en) | Preparation of penicillin and cephalosporin compounds and novel intermediates useful therein | |
| US4150224A (en) | 7[[(1-Pyrrollyl)7 acetyl]amino]cephalosporin derivatives |